These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23305119)

  • 1. High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma.
    Liao R; Sun J; Wu H; Yi Y; Wang JX; He HW; Cai XY; Zhou J; Cheng YF; Fan J; Qiu SJ
    J Exp Clin Cancer Res; 2013 Jan; 32(1):3. PubMed ID: 23305119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma.
    Yan J; Liu XL; Xiao G; Li NL; Deng YN; Han LZ; Yin LC; Ling LJ; Liu LX
    PLoS One; 2014; 9(5):e96080. PubMed ID: 24867183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.
    Kuang DM; Peng C; Zhao Q; Wu Y; Chen MS; Zheng L
    Hepatology; 2010 Jan; 51(1):154-64. PubMed ID: 19902483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.
    Ju MJ; Qiu SJ; Fan J; Xiao YS; Gao Q; Zhou J; Li YW; Tang ZY
    Am J Clin Pathol; 2009 Apr; 131(4):498-510. PubMed ID: 19289585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated microRNA-132 in T helper 17 cells activates hepatic stellate cells to promote hepatocellular carcinoma cell migration in vitro.
    Feng R; Cui Z; Liu Z; Zhang Y
    Scand J Immunol; 2021 May; 93(5):e13007. PubMed ID: 33264420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.
    Zhang JP; Yan J; Xu J; Pang XH; Chen MS; Li L; Wu C; Li SP; Zheng L
    J Hepatol; 2009 May; 50(5):980-9. PubMed ID: 19329213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.
    Zhou ZJ; Xin HY; Li J; Hu ZQ; Luo CB; Zhou SL
    Cancer Immunol Immunother; 2019 Aug; 68(8):1223-1233. PubMed ID: 31201473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma.
    Liao R; Sun TW; Yi Y; Wu H; Li YW; Wang JX; Zhou J; Shi YH; Cheng YF; Qiu SJ; Fan J
    Cancer Sci; 2012 Jun; 103(6):984-92. PubMed ID: 22417086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17C/IL-17 Receptor E Signaling in CD4
    Krohn S; Nies JF; Kapffer S; Schmidt T; Riedel JH; Kaffke A; Peters A; Borchers A; Steinmetz OM; Krebs CF; Turner JE; Brix SR; Paust HJ; Stahl RAK; Panzer U
    J Am Soc Nephrol; 2018 Apr; 29(4):1210-1222. PubMed ID: 29483158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.
    Shi J; Wang Y; Wang F; Zhu Z; Gao Y; Zhang Q; Du Z
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):855-864. PubMed ID: 32205116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17 Producing Cells and RORγt mRNA Transcriptional Factor in Cirrhotic and HCC Egyptian Patients.
    El Bassuoni MA; Soliman MA; El Megeed NA; Al Gazar A
    Egypt J Immunol; 2015; 22(1):59-68. PubMed ID: 26415373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis.
    Hasan I; Gani RA; Lesmana LA; Kresno SB; Pandelaki J; Suwarto S
    Acta Med Indones; 2020 Oct; 52(4):326-333. PubMed ID: 33377877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.
    Zhou BY; Gong JH; Cai XY; Wang JX; Luo F; Jiang N; Gong JP; Du CY; Liao R
    Hepatol Int; 2019 Sep; 13(5):631-640. PubMed ID: 31342250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
    Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
    J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection.
    Wang JX; Yi Y; Li YW; Cai XY; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    BMC Cancer; 2014 Apr; 14():297. PubMed ID: 24774224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.
    Cai XY; Wang JX; Yi Y; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Asian Pac J Cancer Prev; 2014; 15(2):775-80. PubMed ID: 24568494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 Receptor E and C-C Motif Chemokine Receptor 10 Identify Heterogeneous T Helper 17 Subsets in a Mouse Dry Eye Disease Model.
    Wang J; Gong J; Yang Q; Wang L; Jian Y; Wang P
    Am J Pathol; 2022 Feb; 192(2):332-343. PubMed ID: 35144761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.